Astellas Pharma competitors

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis (since 2018).

Dr. William Carson H. is a President and Chief Executive Officer at Otsuka America Pharmaceutical, Inc. and is based in United States.

Craig Landau is a President/CEO at Purdue Biopharma LP and President/CEO at PURDUE PHARMA and is based in Stamford, Connecticut. He has worked as Major at United States Army, Associate Medical Director at Knoll Pharmaceutical Co, and Executive Medical Director at PURDUE PHARMA. Craig attended WINTHROP-UNIVERSITY HOSPITAL between 1991 and 1992, Icahn School of Medicine at Mount Sinai between 1987 and 1991, and Yale University-School of Medicine between 1992 and 1995.

Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, President of the Board of the European Federation of Pharmaceutical Associations (EFPIA), a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world. His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”. As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents